Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03618654
Title Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

head and neck squamous cell carcinoma

Therapies

Durvalumab + Metformin

Durvalumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field